All In Biotech

Drug Trial Radar · NCT00063323

Maintenance Treatment for Abstinent Smokers

Maintenance Treatment for Prevention of Smoking Relapse

Last checked: Nov 20, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 589 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

589

Actual

Start

Aug 2000

Primary completion

Jul 2006

Study completion Jul 2006

Sponsor

Sponsor type
NIH
Collaborators
Research Foundation for Mental Hygiene, Inc.
First posted
Jul 1, 2003

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 21 years, up to 75 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.

Conditions

  • Tobacco Use Disorder

Interventions

  • BupropionDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Survival abstinence rate with maintenance treatmentTime frame: 48 weeks after start of treatment

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • New York State Psychiatric Institute

    New York, New York

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.